Sue Siegel is the CEO of GE's healthymagination initiative to increase access to healthcare while lowering costs. She was previously a partner at Mohr, Davidow Ventures, a top-tier Silicon Valley venture firm, where she led investments in companies focused on personalized medicine, enabling platform technologies for biomedical research, and innovative healthcare businesses with disruptive business models. Prior to joining MDV, Sue was President and Director of Affymetrix, a company that pioneered GeneChip® technology, which helped accelerate the advent of personalized medicine in modern medicine. Sue serves on the board of directors of Pacific Biosciences, Navigenics, RainDance Technologies and On-Q-ity.
Sue is a board member of The Silicon Valley Tech Museum, serves on the Presidents' Circle of the National Academies and as an advisor to the Institute of Medicine. She Chairs the External Relations Committee of The Gladstone Institutes, is a member of YPO, and a Henry Crown Fellow of the Aspen Institute. As part of this Fellowship, Sue and her husband co-founded with Stanford Hospital, Checking-In™, an organization dedicated to serving our aging population. She lives in the San Francisco Bay Area with her husband and sons.
1. Data‐Driven Healthcare. In 2011 and into this next decade, the rate of data generation from biological measurement will continue to accelerate. Making sense of this deluge of data from... Read more »